ZYC101a

contains plasmid-DNA-encoding fragments derived from the E6 and E7 proteins of human papillomavirus (HPV) 16 and 18, and is formulated within small biodegradable microparticles; for treatment of high-grade cervical intraepithelial neoplasia, in a randomized controlled trial (2/2004)

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Beach, Kathleen J: 2 articles (04/2004 - 02/2004)
2.	Crum, Christopher P: 2 articles (04/2004 - 02/2004)
3.	Urban, Robert G: 2 articles (04/2004 - 02/2004)
4.	Hedley, Mary L: 1 article (04/2004)
5.	Lee, Kenneth R: 1 article (04/2004)
6.	Wright, Thomas C: 1 article (04/2004)
7.	Yuan, Liping: 1 article (04/2004)
8.	Braly, Patricia: 1 article (02/2004)
9.	Garcia, Francisco: 1 article (02/2004)
10.	Gold, Michael A: 1 article (02/2004)

Related Diseases

1.	Uterine Cervical Dysplasia 02/01/2004 - "ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial." 04/15/2004 - "Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol." 02/01/2004 - "The objective of this study was to assess the safety and efficacy of a novel therapeutic, ZYC101a, for the treatment of women with histologically confirmed cervical intraepithelial neoplasia (CIN) 2/3. ZYC101a contains plasmid-DNA-encoding fragments derived from the E6 and E7 proteins of human papillomavirus (HPV) 16 and 18, and is formulated within small biodegradable microparticles. "
2.	Papillomavirus Infections 04/15/2004 - "Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol."

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	DNA (Deoxyribonucleic Acid)